Tag: Pharma
AMTZ expands advanced additive manufacturing CoE to boost India’s MedTech component...
The Centre has worked with over 20 startups and 35 industry partners; providing end-to-end support ranging from industrial design and rapid prototyping to machining, post-processing and production
Beyond Trade: How the EU–India FTA reshapes life-sciences industry
The deal represents nearly 25% of global GDP and one-third of global trade, making it one of the most consequential trade agreements of this era
Health Minister J P Nadda releases 10th edition of Indian pharmacopoeia
Indian Pharmacopoeia 2026 expands coverage of anti-TB, anti-diabetic and anti-cancer medicines with 121 new monographs
Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for...
The agreement strengthens Lupin’s diabetes portfolio and accelerates its presence in the obesity segment
Pharma industry leaders spotlight quality, sustainability & market diversification as export...
Indian Pharmacopoeia reinforced as a critical pillar of international credibility, reflecting India’s scientific rigour and regulatory maturity
ICRA retains positive outlook on hospitals, stable on pharma
Hospital sector revenue seen growing 16-18% in FY2026; Pharma revenue projected to expand 9-11%
Biopharma enters 2026 with renewed and cautious optimism, says GlobalData
As per the report’s survey, 52% of pharmaceutical professionals felt optimistic or very optimistic about the industry’s growth in 2026, which is up by 10% compared to data gathered six months ago
SVKM’s NMIMS earns three honours at Indian Pharmaceutical Congress 2025
Event brought together academicians, researchers, and industry professionals from India and abroad to discuss how technology is influencing drug development, quality assurance, and healthcare delivery
Bristol Myers Squibb launches Mosaic: Signals a new era for tech-accelerated...
Demonstrates leadership in AI driven pharma through Accenture partnership
Glenmark bags exclusive multi-regional rights to Aumolertinib from Hansoh Pharma
Partnership strengthens Glenmark’s oncology strategy across high-potential markets